Browse Items (841 total)

• Ebola virus disease

  Tags Ebola, R-Gen, R-Res&Pub, Special Pathogens, Viral Hemorrhagic Fever
  Creator: Jacob, Shevin T., Ian Crozier, William A. Fischer, Angela Hewlett, Colleen S. Kraft, Marc-Antoine de La Vega, Moses J. Soka, Victoria Wahl, Anthony Griffiths, Laura Bollinger, and Jens H. Kuhn.
  Subject: General
  Item Type: Publication
  Date Last Updated: 2020-02-20
  Description: Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus (EBOV).

• Treating Ebola in eastern DRC

  Tags Ebola, Outbreaks, R-Res&Pub, R-T&C, Treatment and Care, Viral Hemorrhagic Fever
  Creator: Rojek, Amanda M., Shevin T. Jacob, and Jake Dunning.
  Subject: Treatment & Care
  Item Type: Publication
  Date Last Updated: 2020-03
  Description: Since the onset of the west Africa Ebola virus outbreak, there has been remarkable progress in efforts to provide patients with improved supportive care and access to experimental treatments.
• 

  NETEC - Online Course - Process and Documentation of Informed Consent for Subjects Involved in Research

  Tags Inform, Informed Consent, R-T&E, Training
  Creator: NETEC
  Subject: Intake and Internal Transport
  Item Type: Online Course
  Date Last Updated: 2020-03
  Description: COURSE DESCRIPTION This course will provide information on many aspects of informed consent and focuses on the unique challenges with special pathogen research. This includes the process of informed consent, general requirements, telephone consent,…

• Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States

  Tags Ebola, Epidemiology, R-Res&Pub, Viral Hemorrhagic Fever
  Creator: Dean, Christina L., Jay W. Hooper, John M. Dye, Samantha E. Zak, Scott A. Koepsell, Laurence Corash, Richard J. Benjamin, Steve Kwilas, Shannon Bonds, Anne M. Winkler, and Colleen S. Kraft.
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2020-03-04
  Description: In 2014, passive immunization by transfusion of Ebola convalescent plasma (ECP) was considered for treating patients with acute Ebola virus disease (EVD).

• Getting to zero in the DR Congo Ebola outbreak

  Tags Ebola, Infection Prevention and Control, R-Res&Pub, R-T&C
  Creator: Dhillon, Ranu S., Devabhaktuni Srikrishna, and Gerardo Chowell.
  Subject: Infection Control
  Item Type: Publication
  Date Last Updated: 2020-03-09
  Description: Any plan to stop the ongoing Ebola outbreak in eastern DR Congo must be based on a quantitative understanding of the proportion of the at-risk population that needs to be protected by effective control measures for transmission to decline…

• Ready or Not, Patients Will Present: Improving Urban Pandemic Preparedness.

  Tags Pandemic, Preparedness, R-EM, R-Res&Pub, Respiratory Pathogen
  Creator: Madad, Syra, Joshua Moskovitz, Matthew R. Boyce, Nicholas V. Cagliuso, and Rebecca Katz.
  Subject: Emergency Management
  Item Type: Publication
  Date Last Updated: 2020-03-16
  Description: Over the past century, society has achieved great gains in medicine, public health, and health-care infrastructure, particularly in the areas of vaccines, antibiotics, sanitation, intensive care and medical technology.

• Chimpanzee adenovirus type 3 vectored Ebola vaccine: expanding the field

  Tags Ebola, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: Bavari, Sina, and Patrick L. Iversen.
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2020-03-19
  Description: Two phase 2 randomised clinical trials evaluating ChAd3-EBO-Z administered to healthy adults in Cameroon, Mali, Nigeria, and Senegal and healthy children in Mali and Senegal are reported by Milagritos Tapia and colleagues in The Lancet Infectious…

• Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

  Tags Ebola, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: Tapia, Milagritos D., Samba O. Sow, Birahim P. Ndiaye, Khardiata D. Mbaye, Aliou Thiongane, Cheikh T. Ndour, Souleymane Mboup, Julie A. Ake, Babajide Keshinro, Gideon A. Akintunde, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche,…
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2020-03-19
  Description: The 2014 Zaire Ebola virus disease epidemic accelerated vaccine development for the virus.

• Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

  Tags Ebola, Pediatrics, R-Res&Pub, R-SP, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: Tapia, Milagritos D., Samba O. Sow, Khardiata D. Mbaye, Aliou Thiongane, Birahim P. Ndiaye, Cheikh T. Ndour, Souleymane Mboup, Babajide Keshinro, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche, Kwadwo A. Koram, Kwaku P. Asante,…
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2020-03-19
  Description: During the large 2013–16 Ebola virus outbreak caused by the Zaire Ebola virus, about 20% of cases were reported in children. This study is the first, to our knowledge, to evaluate an Ebola vaccine in children younger than 6 years.
• 

  PPE CASE Reports: Performance of Stockpiled Air-Purifying Respirators

  Tags Airborne Transmission, N95, Personal Protective Equipment (PPE), R-PPE
  Creator: CDC
  Subject: Infection Control
  Item Type: Hyperlink
  Date Last Updated: 2020-03-25
  Description: Personal Protective Equipment Conformity Assessment Studies and Evaluations (PPE CASE) provide the public with findings from post-market personal protective equipment tests, evaluations, and investigations. On this page NIOSH provides ten PPE CASE…